On the other hand, BM-MSC exosomes can suppress AML, and since our study demonstrated the inhibitory role of MSC-exosomes on the JAK/STAT pathway in AML cells, the use of JAK/STAT pathway inhibitors in combination with BM-MSC exosomes may be a novel approach for AML treatment. Here, SOAT1 is linked to acute myeloid leukemia.